Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-05 | Ms. Patricia LeckmanSenior VP & CPO | -783,00 | 127,30k | Vendita | 161,79 - 167,88 | 21,26k | -3,55% |
| 2026-06-02 | Ms. Patricia LeckmanSenior VP & CPO | -784,00 | 127,07k | Vendita | 160,66 - 163,02 | 22,04k | -3,43% |
| 2026-05-28 | Mr. Keith Arlyn MeisterIndependent Director | -110,42k | 16,29M | Vendita | 147,50 | 2,84M | -3,75% |
| 2026-05-28 | Mr. Keith Arlyn MeisterIndependent Director | -559,17k | 90,76M | Vendita | 156,50 - 165,50 | 2,84M | -16,47% |
| 2026-05-28 | Mr. Keith Arlyn MeisterIndependent Director | -24,56k | 1,32M | Derivative Exercise and Sale | 102,82 - 156,40 | 2,84M | - |
| 2026-05-29 | Mr. Scott DaviesChief Legal Officer & Secretary | -615,00 | 98,40k | Vendita | 160,00 | 21,57k | -2,77% |
| 2026-05-28 | Mr. Scott EricksenVP & CAO | -2,00k | 305,15k | Vendita | 150,10 - 160,00 | 14,45k | -12,16% |
| 2026-05-20 | Ms. Caroline D. DorsaIndependent Director | -1,51k | 214,58k | Sale to Issuer | 141,92 | 13,68k | -9,95% |
| 2026-05-13 | Mr. Keith Arlyn MeisterIndependent Director | -329,46k | 47,93M | Vendita | 144,13 - 148,14 | 3,50M | -8,60% |
| 2026-05-12 | Mr. Keith Arlyn MeisterIndependent Director | -255,38k | 10,69M | Derivative Exercise and Sale | 102,82 - 144,66 | 3,50M | - |
| 2026-05-07 | Mr. Keith Arlyn MeisterIndependent Director | -88,80k | 3,58M | Derivative Exercise and Sale | 102,82 - 143,45 | 3,83M | - |
| 2026-05-05 | Mr. Jakob WedelChief Strategy & Corporate Development Officer | -233,00 | 32,40k | Sale to Issuer | 139,07 | 15,06k | -1,52% |
| 2026-05-06 | Mr. Jakob WedelChief Strategy & Corporate Development Officer | -700,00 | 97,33k | Vendita | 139,04 | 15,06k | -4,44% |
| 2026-02-20 | Mr. Scott DaviesChief Legal Officer & Secretary | -1,34k | 155,22k | Vendita | 116,18 | 16,33k | -7,56% |
| 2026-02-15 | Dr. Steven BarnardCTO | -1,26k | 146,69k | Sale to Issuer | 116,51 | 33,44k | -3,63% |
| 2026-02-15 | Mr. Scott EricksenVP & CAO | -694,00 | 80,86k | Sale to Issuer | 116,51 | 13,23k | -4,98% |
| 2026-02-15 | Mr. Kevin Carl PegelsChief of Global Operations | -1,16k | 135,62k | Sale to Issuer | 116,51 | 22,72k | -4,87% |
| 2026-02-15 | Mr. Scott DaviesChief Legal Officer & Secretary | -1,04k | 120,82k | Sale to Issuer | 116,51 | 17,67k | -5,54% |
| 2026-02-15 | Mr. Jacob ThaysenCEO, Interim Chief Commercial Officer & Director | -6,54k | 762,44k | Sale to Issuer | 116,51 | 40,73k | -13,84% |
| 2026-02-15 | Mr. Jakob WedelChief Strategy & Corporate Development Officer | -578,00 | 67,34k | Sale to Issuer | 116,51 | 10,37k | -5,28% |
| 2026-02-18 | Ms. Patricia LeckmanSenior VP & CPO | -2,37k | 275,35k | Vendita | 116,18 | 16,32k | -12,68% |
| 2026-02-15 | Ms. Patricia LeckmanSenior VP & CPO | -1,30k | 151,93k | Sale to Issuer | 116,51 | 16,32k | -7,40% |
| 2026-02-12 | Dr. Steven BarnardCTO | 1,66k | 0,00 | Derivative Exercise and Retained Stock | - | 34,69k | 5,03% |
| 2026-02-12 | Dr. Steven BarnardCTO | -1,01k | 116,04k | Derivative Exercise and Sale | 114,44 | 34,69k | - |
| 2026-02-12 | Mr. Jacob ThaysenCEO, Interim Chief Commercial Officer & Director | 7,79k | 0,00 | Derivative Exercise and Retained Stock | - | 34,53k | 29,15% |
| 2026-02-12 | Mr. Jacob ThaysenCEO, Interim Chief Commercial Officer & Director | -5,47k | 625,99k | Derivative Exercise and Sale | 114,44 | 34,53k | - |
| 2026-02-12 | Mr. Kevin Carl PegelsChief of Global Operations | 1,41k | 0,00 | Derivative Exercise and Retained Stock | - | 23,89k | 6,27% |
| 2026-02-12 | Mr. Kevin Carl PegelsChief of Global Operations | -874,00 | 100,02k | Derivative Exercise and Sale | 114,44 | 23,89k | - |
| 2026-02-12 | Mr. Scott DaviesChief Legal Officer & Secretary | 820,00 | 0,00 | Derivative Exercise and Retained Stock | - | 18,71k | 4,58% |
| 2026-02-12 | Mr. Scott DaviesChief Legal Officer & Secretary | -550,00 | 62,94k | Derivative Exercise and Sale | 114,44 | 18,71k | - |
| 2026-02-12 | Ms. Patricia LeckmanSenior VP & CPO | 604,00 | 0,00 | Derivative Exercise and Retained Stock | - | 20,00k | 3,11% |
| 2026-02-12 | Ms. Patricia LeckmanSenior VP & CPO | -424,00 | 48,52k | Derivative Exercise and Sale | 114,44 | 20,00k | - |
| 2026-02-12 | Mr. Scott EricksenVP & CAO | 437,00 | 0,00 | Derivative Exercise and Retained Stock | - | 13,92k | 3,24% |
| 2026-02-12 | Mr. Scott EricksenVP & CAO | -306,00 | 35,02k | Derivative Exercise and Sale | 114,44 | 13,92k | - |
| 2026-02-09 | Dr. Scott GottliebIndependent Chairman | 200,00 | 23,56k | Acquisto | 117,81 | 8,94k | 2,29% |
| 2025-12-12 | Mr. Scott DaviesChief Legal Officer & Secretary | -323,00 | 43,96k | Vendita | 136,09 | 17,89k | -1,77% |
| 2025-12-08 | Mr. Jakob WedelChief Strategy & Corporate Development Officer | -549,00 | 70,97k | Vendita | 129,27 | 10,95k | -4,77% |
| 2025-12-05 | Mr. Jakob WedelChief Strategy & Corporate Development Officer | -307,00 | 39,59k | Sale to Issuer | 128,96 | 10,95k | -2,73% |
| 2025-11-12 | Mr. Scott DaviesChief Legal Officer & Secretary | -323,00 | 39,66k | Sale to Issuer | 122,79 | 18,21k | -1,74% |
| 2025-11-05 | Mr. Scott DaviesChief Legal Officer & Secretary | -398,00 | 48,73k | Sale to Issuer | 122,44 | 18,53k | -2,10% |
| 2025-11-05 | Mr. Scott EricksenVP & CAO | -206,00 | 25,22k | Sale to Issuer | 122,44 | 13,49k | -1,50% |
| 2025-11-05 | Ms. Patricia LeckmanSenior VP & CPO | -296,00 | 36,24k | Sale to Issuer | 122,44 | 19,39k | -1,50% |
| 2025-11-05 | Mr. Kevin Carl PegelsChief of Global Operations | -599,00 | 73,34k | Sale to Issuer | 122,44 | 22,48k | -2,60% |
| 2025-11-05 | Dr. Steven BarnardCTO | -515,00 | 63,06k | Sale to Issuer | 122,44 | 33,03k | -1,54% |
| 2025-11-03 | Dr. Scott GottliebIndependent Chairman | 500,00 | 61,07k | Acquisto | 122,13 | 8,74k | 6,07% |
| 2025-10-05 | Mr. Jacob ThaysenCEO, Interim Chief Commercial Officer & Director | -1,30k | 131,43k | Sale to Issuer | 101,02 | 26,74k | -4,64% |
| 2025-09-05 | Dr. Steven BarnardCTO | -287,00 | 28,39k | Sale to Issuer | 98,93 | 33,55k | -0,85% |
| 2025-07-05 | Mr. Everett V. CunninghamInsider | -4,25k | 412,69k | Sale to Issuer | 97,15 | 9,84k | -30,14% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
